Prof. Richard E. Gliklich OM1, USA1 Talk
Dr. Rich Gliklich is CEO of OM1, Inc, a data and technology company focused on using deep clinical data and advanced analytics to measure and predict health outcomes for value-based care. Rich was Founder and CEO of Outcome Sciences, a registries and comparative effectiveness company that served more than 2500... read morehealthcare organizations and a majority of the global top 30 lifesciences companies. Rich led Outcome for 13 years through its acquisition by Quintiles in 2011 and then stayed on at Quintiles through its 2013 IPO. After that, Rich joined General Catalyst Partners as an XIR focused on investments in healthcare companies until founding OM1 in 2015.
Rich is PI and senior editor of the Agency for Healthcare Research and Quality (AHRQ)’s Registries for Evaluating Patient Outcomes: A User’s Guide 1st-4th editions and for the Outcomes Measures Framework effort in outcomes standardization.
Rich is a graduate of Yale University and Harvard Medical School and a former Charles A. Dana Scholar at the University of Pennsylvania. Rich is also a surgeon and is the Leffenfeld Professor at Harvard Medical School.